469
Views
14
CrossRef citations to date
0
Altmetric
Original Articles

Extraction and analysis of pharmaceuticals in polluted sediment using liquid chromatography mass spectrometry

, &
Pages 553-566 | Received 13 Jul 2009, Accepted 27 Jan 2010, Published online: 11 Apr 2011
 

Abstract

A multi-residue method for the extraction and clean-up of sediment samples was developed for the analysis of pharmaceutical residues. Sediment samples were collected in the proximity of sewage water plant in Stockholm, Sweden. Target analytes were the basic β-blocker propranolol, the neutral neuroleptic carbamazepine and the acidic anticoagulant warfarin, the painkiller diclofenac and the lipid regulator gemfibrozil. The extraction solvent was optimised with regard to pH and organic modifer. Extraction and clean up were performed with liquid-liquid extraction and ultra-sonication followed by solid-phase extraction. One extraction solvent, containing acetone/McIlvaine buffer pH4, provided satisfactory extraction for all substances. LC/MSMS in the MRM mode was used for determination. The recoveries of the extraction and clean-up steps were 60–75% (±2–8%) and LOQs were in the range 0.4–8 ng/g sediment (dry weight). The pharmaceuticals found in the sediment samples were propranolol and carbamazepine, representing substances with basic and neutral properties. Additionally, the samples were analysed with LC/QTOF for verification with the use of accurate mass measurement in the full-scan mode. Pharmaceuticals not represented in the original method were looked for. Non-target pharmaceuticals found using the LC/QTOF system were the basic β-blocker metoprolol and the acidic painkiller naproxen.

Acknowledgements

The study was financially supported by the Swedish research council Formas. Per Jonsson, Michael McLachlan, Hildred Crill, Jörgen Ek and Urs Berger (Stockholm University) are acknowledged for their support.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.